A literature search of the electronic databases, MEDLINE and EMBASE, was conducted on 18th June 2012 to identify all relevant studies describing complications of catheter ablation of AF. A detailed search methodology is presented in the online-only Data Supplement. This was supplemented by hand-searching bibliographies of retrieved articles as well as relevant review articles.
C atheter ablation of atrial fibrillation (AF) is an established rhythm control strategy in symptomatic AF. [1] [2] [3] [4] The procedure aims to eliminate triggers and substrate that initiate, perpetuate, and sustain AF. Because catheter technology improves and experience increases, wider inclusion criteria are being used to select patients. Indeed, selected patients may benefit from ablation as first-line therapy. 5 A recent study reporting the outcomes of 2 meta-analyses found a 77% success rate for catheter ablation versus 52% for antiarrhythmic drugs. 6 Several randomized controlled trials have reported similar results. [6] [7] [8] [9] [10] A meta-analysis of 4 of these studies found a >3.7-fold probability of freedom from AF with ablation compared with medical therapy.
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Clinical Perspective on p 1088
Catheter ablation can be associated with significant complications. Safety data reported from high-volume single-center series and the results of a recent international survey are inconsistent with regards to the incidence of acute complications ranging from <1% to 6%. [12] [13] [14] [15] [16] [17] Furthermore, few studies have investigated the relationship between procedural variables and the complication rate. These have been limited to single-center series where low event rates have limited the identification of statistically significant predictors, and the applicability of results to other treatment settings is unclear.
retrospective designs were included. Abstracts, case reports, editorials, comments, conference proceedings, meta-analyses, and review articles were excluded. Studies involving surgical ablation, atrioventricular nodal ablation, exclusive right atrial ablation, or ablate-and-pace strategies were excluded. Animal and in vitro studies, as well as studies in languages other than English, were also excluded. Studies were included if there were ≥100 patients in the treatment arm. This minimum number was chosen to increase the likelihood of retrieving the best quality studies, as well as to exclude case reports and small series. These may have otherwise misrepresented the true incidence of rare adverse events by selectively reporting these cases in often niche patient subgroups, and so potentially confound the analysis for an overall complication rate. A study attrition diagram showing the number and reasons for exclusion of publications from the originally retrieved citations is presented in the Figure. Clinical trials comparing variations in catheter ablation technique and equipment were included with data from different treatment groups combined to create a single-arm study for data analysis. This reflected our objective to evaluate the overall safety of catheter ablation in context of its current application in different forms worldwide.
Citations were appraised by 2 independent reviewers with differences resolved by consensus. Data extracted recorded acute complication rate, rates and types of periprocedural adverse events, mean procedure and radiofrequency time; and ablation strategy subcategorized as:
1. Pulmonary vein (PV) isolation: ostial ablation of all PVs with confirmation of electric block. 2. PV antral ablation with or without isolation: antral anatomic ablation around the PVs with or without PV isolation. 3. Linear substrate ablation as an adjunct to PV ablation. This includes roofline, mitral isthmus, anterior line, and posterior left atrial isolation. 4. Complex fractionated atrial electrogram (CFAE) ablation. 5. CFAE as an adjunct to conventional approaches (CFAE+PV isolation/PV antral ablation/PV antrum isolation/linear ablation). 6. Tailored approach: PV ablation with adjunctive linear and CFAE ablation performed at operator discretion. 7. Stepwise ablation approach: PV ablation, followed by linear substrate ablation and CFAE.
Assessment of Methodological Quality
Study quality was assessed based on criteria used by a recent systematic review that included case series 19 together with guidelines from the NHS Center for Reviews and Dissemination. 20 A list of 8-quality items was developed addressing both internal validity, principally selection bias and quality of complication reporting, and external validity of the study. The criteria used are presented in the online-only Data Supplement. The study followed the Meta-analysis of Observational Studies in Epidemiology proposal for reporting.
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Statistical Analysis
For the purpose of meta-analysis, the percentage of procedures resulting in complications was first transformed using the FreemanTukey arcsin transformation. 22 Transformed estimates were then pooled across studies using the DerSimonian-Laird random effects method. 23 Heterogeneity between studies was quantified using the I 2 statistic. 24 Pooled estimates and their 95% confidence intervals (CIs) were back transformed to give summary percentages.
To explore potential sources of heterogeneity, several prespecified subgroup analyses were performed. Separate meta-analyses were performed according to whether the study prospectively listed complications, year of publication (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) , mean procedure time (0-2, 2-4, and >4 hours), mean radiofrequency ablation time (0-60 and >60 minutes), and ablation strategy (1) (2) (3) (4) (5) (6) (7) . To compare the percentage of procedures with complications across subgroups, Wald tests based on the transformed proportions were performed. A 2-tailed P value <0.05 was considered statistically significant. All calculations were performed using Stata version 12.
Results
Study Characteristics
A total of 192 studies, comprising 83 236 patients, met the inclusion criteria. Online-only Data Supplement presents the baseline characteristics of these studies. Included studies were published in years 2001 to 2012. The studies consisted of 87 case series: 60 studies with a cohort design, 10 casecontrol studies, 2 cross-sectional studies, and 34 randomized controlled trials. Study size varied considerably, from the minimum of n=100 patients in 21 studies to much larger studies with a maximum of n=6454 patients. 25 A complete bibliography of included studies is presented in the onlineonly Data Supplement.
Patient Demographics
Patient demographics for the entire study population are shown in Table 1 . Participants in the included studies were between 51 and 77 years.
Analysis of Complications
The overall acute complication rate was 2.9% (95% CI, 2.6-3.2) although there was substantial heterogeneity between studies (I 2 =83.8%). Table 2 presents the pooled relative incidence of reported complications and the number of studies contributing to each analysis. Vascular complications were the most common (1.4%), and then tamponade (1.0. %), pericardial effusion (0.7%), stroke/transient ischemic attack (0.6%), and significant pulmonary vein stenosis (0.5%). The incidence of procedure-related deaths was 0.06%. Atrioesophageal fistula occurred in 0.1% and phrenic nerve injury in 0.4%. A list of complications reported in addition to those in our predefined list is presented in the online-only Data Supplement. Included in the studies reporting complications were 33 randomized controlled trials. The frequency of complications reported in the ablation arm of these studies was 2.4%. This did not differ from other studies describing data retrospectively. A further potential issue is the risk of double inclusion of patients from separate studies. Specific consideration in this regard is to the 2 registry-based studies of Bertaglia et al 12 and Hunter et al. 26 To overcome this, we performed a secondary analysis excluding these studies. The risk of complications in this reduced cohort was 2.9% (95% CI, 2.6-3.2), unchanged from the main analysis.
Comparing Contemporary and Earlier Data
There has been a significant decrease in the complication rates during the past 6 years (2007-2012) compared with the preceding 6 years (2000-2006; 2.6% versus 4.0%; P=0.003). Table 3 provides a contemporary estimate of complication rates, including data from the 140 studies published between 2007 and 2012.
Prospective Definition of Complications
The complication rate was significantly higher in studies that prospectively defined complications (3.5%; 95% CI, 2.9-4.1), compared with retrospective studies (2.7%; 95% CI, 2.3-3.1; P=0.03). Table 4 portrays estimates of the incidence of specific complications based on data from the 42 prospective studies.
Impact of Procedural Factors
The complication rate was observed to be higher with procedures lasting >240 minutes (3.3%; 95% CI, 2.6-4.1; P=0.3), and those lasting120-240 minutes (2.9%; 95% CI, 2.4-3.4; P=0.6), compared with procedures of duration <120 minutes (2.5%; 95% CI, 1.5-3.9). These differences, however, were not significant. The complication rate for procedures with a radiofrequency application time >60 minutes (2.8%; 95% CI, 2.0-3.7) was similar to that for those ≤60 minutes (2.6%; 95% CI, 2.1-3.1; P=0.7).
Impact of Ablation Strategy
No individual ablation strategy was associated with a higher complication rate when compared with PV isolation alone, as illustrated in Table 5 .
Discussion
This systematic review evaluates the temporal trends and procedural predictors of complications of catheter ablation of AF. The study included >83 000 patients undergoing AF ablation, in whom complications have been reported. The overall incidence of complications was 2.9%. This is lower than rates reported in the updated worldwide survey (4.5%) and in a recent meta-analysis of AF ablation (4.9%). 6, 13 There was also a lower pooled incidence of procedure-related deaths (0.06%) compared with results of the updated worldwide survey (0.15%) and another survey, which specifically investigated fatal outcomes during AF ablation (0.1%). 13, 27 Reasons for this may include that this study incorporates the most recent published literature on safety data, reflecting contemporary catheter technology and techniques, as well as increased experience. There is also potential for publication bias to contribute as this may favor the publication of studies demonstrating low complication rates.
Comparing Contemporary and Earlier Data
A survey of catheter ablation for AF in 2005 reported a 6% incidence of major complications. 17 An update of this survey in 2010 reported a 4.5% complication rate. 13 There has been further evidence of a declining incidence of complications, 28, 29 with a large single-center series reporting a decrease in complication rate from 11.1% in 2002 to 1.6% in 2010. 30 The results of this meta-analysis support such observational data, demonstrating a significant decrease in the complication rate to 2.6% during the past 6 years. Although more complex procedures are being undertaken in higher risk patients, and more new centers are offering intervention, catheter ablation is becoming a safer therapy. This is likely to be related to refinements in ablation technique, technology, and increased experience.
Prospective Definition
Higher complication rates were reported in studies that prospectively defined major complications. This suggests that current accuracy and potential reporting bias in retrospective may limit present estimates of complication rates.
Procedural Predictors
Complication rates were observed to be higher with increasing procedure duration; however, this was not statistically significant. There was no association found between radiofrequency time and complications. No individual ablation strategy showed a significant difference in complication rate compared with PV isolation although there was a trend toward increased complications with CFAE-based ablation. These results are consistent with large single-center series that have investigated procedural variables with no significant predictors of complications. 16, 31 It is reassuring to see these results reproduced in a global context with heterogeneous study settings, considering the current application of ablation in different forms. *Pulmonary vein stenosis defined as >50% stenosis and requiring intervention. †Vascular complications included bleeding, hematoma, arteriovenous fistula, and femoral pseudoaneurysm. December 2013
Limitations
All studies had a quality score of ≥4 of 8, and 57 studies had good scores of 7 to 8. Limiting included studies to those with ≥100 participants may have been important in preselecting studies with higher quality designs. The decision not to use quality features to determine inclusion seems appropriate in view of the finding by Dalziel et al that there is no clear relationship between quality features and outcomes of case series. 32 Only 45 of the studies prospectively defined major complications. This may be significant as these studies report higher complication rates. This meta-analysis primarily used data of nonrandomized studies. However, this study found that the frequency of complications in the randomized controlled trials alone was similar to that for the group of studies as a whole. Subgroup analyses at the meta-analysis level were used to determine the temporal trends and procedural predictors of complications. As a subgroup limitation, this meant it was not feasible to determine the individual patient characteristics that may be associated with particular complications. This review included a broad range of study designs, patient populations, as well as catheter technologies. Although conducting meta-analyses across disparate study settings may appear of concern, this approach enabled our review to reflect the performance of AF ablation in the population as a whole. These results are also supported large prospective case series that have investigated complication rates and procedural predictors. 16, 31 An important methodological challenge in conducting largescale systematic reviews is avoiding the double inclusion of some patient populations. To this end, all review articles, metaanalyses, and international surveys were excluded from statistical analysis to avoid the double inclusion of entire studies. It cannot, however, be excluded that multiple articles from large ablation centers or centers included in a multi-center registry may have had overlapping patient populations. We conducted a reduced analysis excluding key registry studies and found no change in the risk of complications. The effect of double-counting is likely minimized by the inclusion of 192 different studies with >83 000 patients. Limiting included data to published studies may lead to the potential for publication bias, which may favor publication of studies, particularly from high volume centers, demonstrating low complication rates. This may result in an underestimation of the overall complication rate. The alternative, however, which is to collect data by approaching individual centers, also has inherent potential for selection bias, as demonstrated in the Updated Worldwide Survey, in which only 85 of 521 centers contacted responded. 13 It may be the case that centers with higher complication rates are less willing to voluntarily disclose data related to complications. The California study of Medicare Beneficaries undergoing catheter ablation for AF is one of the largest studies that include data from lower volume centers. 33 The estimated incidence of major complications was generally higher than those found in this study: death 0.8% versus 0.06%, stroke/transient ischemic attack 0.8% versus 0.58%, and pericardial effusion 1.7% versus 0.7%. It is important to recognize, however, that all patients in this study were >65 years, and the mean age was 72 years, compared with 57.3 years in this study. This is likely to have had an important impact on the periprocedural complication rate, along with the inclusion of results from lower volume centers. There is a limitation to the real-world application of results derived from publications dependent on self-reporting by research centers or by centers participating in surveys.
Conclusions
This review established a low complication rate and periprocedural mortality of catheter ablation of AF. It then provided an encouraging insight into the downward temporal trend in the incidence of complications as catheter technology improves, ablation techniques refined, and experience increases. Finally, the results were also reassuring in demonstrating that complication rates are not significantly related to procedure duration, ablation time, or ablation technique. The current use of different ablation strategies worldwide seems to be safe and appropriate in the continuing endeavor to establish the most efficacious approach for rhythm control of AF. 
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